Densitas®, a global leader in artificial intelligence for breast cancer screening, has launched intelliRisk™, a new platform designed to manage high-risk breast cancer patients. This addition to Densitas’ portfolio, which already includes intelliMammo® and intelliMaven™, enhances the company’s capabilities in the management of high-risk breast cancer patients.

intelliRisk offers healthcare providers a streamlined approach to identifying, assessing, and managing high-risk patients. By incorporating established guidelines and recommendations, the platform supports clinical decision-making tailored to each patient.

It is available as a standalone web application or can be integrated with existing EHR systems, helping to guide personalised screening and patient management workflows in line with best practices. This solution aims to improve provider efficiency and patient outcomes by optimising breast cancer care.

The platform is designed to support healthcare professionals across various fields, including breast imaging, oncology, genetics, and population health, by improving both operational and clinical workflows. By providing lifetime breast cancer risk assessments and managing high-risk patients, intelliRisk supports the core principles of quality mammography services:

• Quality: The platform delivers precise, personalised breast cancer risk assessments to ensure treatment plans are tailored to each patient’s individual risk.
• Efficiency: Seamless data integration provides fast access to comprehensive risk insights, enabling quicker decision-making and improved patient management.
• Compliance: intelliRisk helps healthcare providers meet clinical guidelines by offering a structured approach to identify, track, and document high-risk patients, ensuring alignment with national cancer care standards.
• Sustainability: The platform prioritises proactive management, optimising resource allocation and encouraging preventative measures and targeted surveillance over time.

This strategic move aligns with Densitas’ goal to provide a cohesive solution for breast cancer risk assessment, breast density, and mammography quality service delivery in a way that enhances patient care and improves operational efficiency. With intelliRisk, healthcare teams can engage patients before they visit the clinic, offering personalised risk assessments and educational resources for convenient access.

The combination of intelliRisk and intelliMammo creates a seamless experience, improving patient understanding and encouraging adherence to follow-up care, while helping providers deliver high-quality care and efficient operational workflows.

 

 

 

Source: densitashealth.com

Report Abuse